The Journal of Immunology, Vol 138, Issue 4 1115-1120, Copyright © 1987 by American Association of Immunologists

ARTICLES

The cyclosporins inhibit lymphocyte activation at more than one site

EW Gelfand, RK Cheung and GB Mills

Cyclosporin A (CsA), a potent immunosuppressive agent, acts primarily by inhibiting T cell function. Although several potential sites of action have been identified, the mechanisms whereby CsA mediates its immunosuppressive properties have not been fully delineated. We have examined the effects of the immunosuppressive cyclosporins, CsA, dihydrocyclosporin D, and cyclosporin G, and a nonimmunosuppressive analog, cyclosporin H, on early events associated with activation of human T cells. Interleukin 2 (IL 2) receptor expression, as measured by immunofluorescence, was unaffected by CsA. Despite this, in the continuous presence of CsA, exogenous IL 2 did not bypass CsA inhibition of phytohemagglutinin (PHA)-induced proliferation. Thus, one site of activity of CsA is on IL 2-induced proliferation of IL 2 receptor-expressing cells. In addition, several potential mechanisms for inhibiting IL 2 secretion were identified. Changes in cytosolic free Ca2+ ([Ca2+]i), an obligatory event for PHA-induced IL 2 secretion, were inhibited by a 30-min preincubation with the immunosuppressive cyclosporins but not the inactive analog. In this action, the drug effects cannot be distinguished from that of Ca2+ channel blockers. The active compounds also resulted in membrane depolarization, an effect which may, in part, explain the reduction in PHA-induced changes in [Ca2+]i. These results identify multiple sites of action of the immunosuppressive cyclosporins, the combination of which likely accounts for their selective inhibition of T cell function in vitro and in vivo.

This article has been cited by other articles:

				P. Bullon, I. Gallardo, G. Goteri, C. Rubini, M. Battino, J. Ribas, and H.N. Newman Nifedipine and Cyclosporin Affect Fibroblast Calcium and Gingiva Journal of Dental Research, April 1, 2007; 86(4): 357 - 362. [Abstract] [Full Text] [PDF]

				M. Saini and M. J. Potash Novel Activities of Cyclophilin A and Cyclosporin A during HIV-1 Infection of Primary Lymphocytes and Macrophages J. Immunol., July 1, 2006; 177(1): 443 - 449. [Abstract] [Full Text] [PDF]

				J. Ezendam, I. Hassing, R. Bleumink, J. G. Vos, and R. Pieters Hexachlorobenzene-induced Immunopathology in Brown Norway Rats is Partly Mediated by T Cells Toxicol. Sci., March 1, 2004; 78(1): 88 - 95. [Abstract] [Full Text] [PDF]

				T. Ishizuka, K. Chayama, K. Takeda, E. Hamelmann, N. Terada, G. M. Keller, G. L. Johnson, and E. W. Gelfand Mitogen-Activated Protein Kinase Activation Through Fc{epsilon} Receptor I and Stem Cell Factor Receptor Is Differentially Regulated by Phosphatidylinositol 3-Kinase and Calcineurin in Mouse Bone Marrow-Derived Mast Cells J. Immunol., February 15, 1999; 162(4): 2087 - 2094. [Abstract] [Full Text] [PDF]

				B. S. McAllister, J. D. Walters, and M. S. Olson Signal Transduction Mechanisms in Mesenchymal Cells Critical Reviews in Oral Biology & Medicine, January 1, 1994; 5(3): 291 - 310. [Abstract] [Full Text] [PDF]

				T. M. Hassell and A. F. Hefti Drug-Induced Gingival Overgrowth: Old Problem, New Problem Critical Reviews in Oral Biology & Medicine, January 1, 1991; 2(1): 103 - 137. [Full Text] [PDF]